VYNE Therapeutics Inc.
For the period ended Dec 31, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 27, 2026
YARW$15.79+1.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 2. Properties
Our previous executive offices in the United States were located in Bridgewater, New Jersey. We leased approximately 5,755 square feet of office space under lease agreements, which expired on October 31, 2025. Starting November 1, 2025, the Company began operating on a fully remote model.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.